SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-21-000031
Filing Date
2021-11-10
Accepted
2021-11-10 16:18:50
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20211110.htm   iXBRL 8-K 38305
2 EX-99.1 exhibit991q32021earningsre.htm EX-99.1 81600
6 GRAPHIC image_0a.jpg GRAPHIC 16017
  Complete submission text file 0001587221-21-000031.txt   286413

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20211110.xsd EX-101.SCH 1939
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20211110_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20211110_pre.xml EX-101.PRE 12666
7 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20211110_htm.xml XML 10811
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 211396920
SIC: 2834 Pharmaceutical Preparations